Kwality Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, sales was INR 1,260.24 million compared to INR 3,039.5 million a year ago. Revenue was INR 1,271.53 million compared to INR 3,050.23 million a year ago. Net income was INR 195.64 million compared to INR 939.73 million a year ago. Basic earnings per share from continuing operations was INR 18.56 compared to INR 90.29 a year ago. Diluted earnings per share from continuing operations was INR 18.56 compared to INR 90.29 a year ago.